HomeContact UsProduct LinksSite MapSearch   
About BioMarin Products Pipeline Fully Integrated


 


 
   
LATEST NEWS
08/05/08: BioMarin Announces Second Quarter 2008 Financial Results
 
07/22/08: BioMarin and Summit plc Sign Worldwide Licensing Agreement for Duchenne Muscular Dystrophy Program
 
07/16/08: Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
 
07/15/08: BioMarin to Host Second Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, August 5 at 5:00 p.m. ET (23:00 CET)
 
07/01/08: BioMarin to Present at the Collins Stewart Growth Conference
 
06/05/08: BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
 
05/22/08: BioMarin to Host Research and Development Day June 5th
 
05/20/08: BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
 
05/07/08: BioMarin to Present at the Bank of America Healthcare Conference
 
05/06/08: BioMarin to Present at the Baird Growth Stock Conference
 
04/29/08: BioMarin Announces First Quarter 2008 Financial Results
 
04/24/08: BioMarin to Present at the Morgan Stanley Healthcare Conference
 
04/08/08: BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET)
 
03/31/08: Naglazyme Approved by Japanese Ministry of Health
 
03/12/08: BioMarin to Present at the Lehman Brothers Global Healthcare Conference
 
03/11/08: BioMarin to Present at the Citi Small & Mid-Cap Conference
 
03/11/08: BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
 
02/26/08: BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
 
01/30/08: BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
 
01/28/08: BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
 
01/23/08: BioMarin to Present at the Wachovia 2008 Healthcare Conference
 
01/22/08: Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
 
01/03/08: BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture



  © 2006 BIOMARIN
  LEGAL NOTICE GLOSSARY
Last updated: 05/13/2008